--- title: "Thermo Fisher Scientific Inc. (NYSE:TMO) Declares $0.47 Quarterly Dividend" type: "News" locale: "en" url: "https://longbridge.com/en/news/292314965.md" description: "Thermo Fisher Scientific (NYSE:TMO) declared a quarterly dividend of $0.47 per share. The ex-dividend and record dates are September 15, with payment on October 15. This yields 0.4% annually. The company has raised its dividend for eight consecutive years, supported by a low payout ratio of 7.6%. Recent earnings beat estimates, with EPS of $5.44 and revenue up 6.2% year-over-year." datetime: "2026-07-10T11:30:13.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/292314965.md) - [en](https://longbridge.com/en/news/292314965.md) - [zh-HK](https://longbridge.com/zh-HK/news/292314965.md) --- # Thermo Fisher Scientific Inc. (NYSE:TMO) Declares $0.47 Quarterly Dividend **Thermo Fisher Scientific Inc.** (NYSE:TMO - Get Free Report) declared a quarterly dividend on Thursday, July 9th. Investors of record on Tuesday, September 15th will be given a dividend of 0.47 per share by the medical research company on Thursday, October 15th. This represents a c) annualized dividend and a yield of 0.4%. The ex-dividend date of this dividend is Tuesday, September 15th. - The Market Is Selling Everything, but These 5 Stocks Aren't Breaking Down Thermo Fisher Scientific has raised its dividend payment by an average of 0.1%per year over the last three years and has raised its dividend annually for the last 8 consecutive years. Thermo Fisher Scientific has a payout ratio of 7.6% meaning its dividend is sufficiently covered by earnings. Analysts expect Thermo Fisher Scientific to earn $27.18 per share next year, which means the company should continue to be able to cover its $1.88 annual dividend with an expected future payout ratio of 6.9%. ## Thermo Fisher Scientific Stock Up 2.6% Shares of NYSE:TMO opened at $523.58 on Friday. The company has a current ratio of 1.53, a quick ratio of 1.15 and a debt-to-equity ratio of 0.77. The firm has a market cap of $194.57 billion, a price-to-earnings ratio of 28.78, a PEG ratio of 2.26 and a beta of 0.87. The stock's 50-day moving average price is $477.01 and its two-hundred day moving average price is $516.37. Thermo Fisher Scientific has a 12-month low of $403.36 and a 12-month high of $643.99. - The Often-Missed Corner of Healthcare That Wall Street Is Loving Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last announced its quarterly earnings data on Thursday, April 23rd. The medical research company reported $5.44 earnings per share for the quarter, topping the consensus estimate of $5.25 by $0.19. Thermo Fisher Scientific had a net margin of 15.15% and a return on equity of 16.86%. The business had revenue of $11.01 billion for the quarter, compared to analyst estimates of $10.86 billion. During the same period in the prior year, the firm posted $5.15 EPS. The company's revenue was up 6.2% on a year-over-year basis. Thermo Fisher Scientific has set its FY 2026 guidance at 24.640-25.120 EPS. On average, research analysts forecast that Thermo Fisher Scientific will post 24.84 EPS for the current year. ## About Thermo Fisher Scientific (Get Free Report) Thermo Fisher Scientific NYSE: TMO is a global provider of scientific instrumentation, reagents and consumables, software, and services that support research, clinical, and industrial laboratories. The company supplies analytical instruments and laboratory equipment, life sciences reagents and kits, specialty diagnostics, and a broad range of consumables used by researchers, clinicians, and manufacturers. Its offerings also include laboratory information management and data-analysis software, as well as service solutions such as instrument maintenance, validation, and logistics that help customers run complex workflows efficiently. - Sector Rotation: 2 Smart Money Moves for 2026 Thermo Fisher operates through multiple business areas that broadly cover life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services, including contract development and manufacturing for pharmaceutical and biotechnology companies. ## Featured Articles - Five stocks we like better than Thermo Fisher Scientific - PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth - Dollar Tree’s Turnaround Is Starting to Take Root - Why Levi's Digital Strategy Is Paying Off in a Big Way - Constellation Brands: Beer Growth and Buybacks Mask Stock's Slump _This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com._ ## Should You Invest $1,000 in Thermo Fisher Scientific Right Now? Before you consider Thermo Fisher Scientific, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Thermo Fisher Scientific wasn't on the list. While Thermo Fisher Scientific currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here ### Related Stocks - [TMO.US](https://longbridge.com/en/quote/TMO.US.md) - [PSMT.US](https://longbridge.com/en/quote/PSMT.US.md) - [DLTR.US](https://longbridge.com/en/quote/DLTR.US.md) - [LEVI.US](https://longbridge.com/en/quote/LEVI.US.md) - [STZ.US](https://longbridge.com/en/quote/STZ.US.md) ## Related News & Research - [Thermo Fisher Scientific (TMO) Stock Faces Margin Stagnation That Tests Bullish Earnings Narrative](https://longbridge.com/en/news/293818701.md) - [Bowen Hanes & Co. Inc. Sells 83,910 Shares of Thermo Fisher Scientific Inc. $TMO](https://longbridge.com/en/news/293721447.md) - [Thermo Fisher Scientific Inc Stock (TMO) Moved Up by 9.89% on Jul 23: A Full Analysis](https://longbridge.com/en/news/293645248.md) - [Thermo Fisher Scientific (NYSE:TMO) Updates FY 2026 Earnings Guidance](https://longbridge.com/en/news/293626208.md) - [Thermo Fisher Rated Buy on Broad-Based Recovery, Conservative Guidance, and Attractive Valuation Versus Peers](https://longbridge.com/en/news/293715975.md)